1.1 Continuous abstinence at post‐treatment |
1 |
112 |
Risk Ratio (M‐H, Random, 95% CI) |
0.96 [0.44, 2.14] |
1.2 Continuous abstinence at follow‐up |
1 |
112 |
Risk Ratio (M‐H, Random, 95% CI) |
1.04 [0.54, 2.01] |
1.3 Percentage days with substance use at post‐treatment |
4 |
248 |
Std. Mean Difference (IV, Random, 95% CI) |
0.05 [‐0.37, 0.47] |
1.4 Percentage days with substance use at follow‐up |
3 |
167 |
Std. Mean Difference (IV, Random, 95% CI) |
0.21 [‐0.12, 0.54] |
1.5 Consumed amount at post‐treatment |
3 |
221 |
Std. Mean Difference (IV, Random, 95% CI) |
0.10 [‐0.31, 0.52] |
1.6 Consumed amount at follow‐up |
2 |
142 |
Std. Mean Difference (IV, Random, 95% CI) |
0.33 [0.00, 0.66] |
1.7 Craving intensity at post‐treatment |
2 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.8 Treatment acceptability (attrition) |
21 |
1087 |
Risk Ratio (M‐H, Random, 95% CI) |
1.04 [0.77, 1.40] |
1.9 Treatment acceptability (attrition): sensitivity analysis (fixed‐effects model) |
21 |
1087 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.13 [0.84, 1.50] |